Screener
Health Catalyst HCAT Contingent consideration fair value adjustments
Contingent consideration fair value adjustments at other companies
Other financials
Where this comes from
Reported directly by Health Catalyst in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The source filing: Health Catalyst’s 10-Q, filed November 10, 2025.
- Filed
- Nov 10, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001636422-25-000146
| Line item | Nine Months Ended September 30, 2025 | Nine Months Ended September 30, 2024 |
|---|---|---|
| Investment discount and premium accretion | (1,278) | (3,899) |
| Provision for expected credit losses | 1,410 | 3,433 |
| Deferred tax provision | (114) | (517) |
| Change in fair value of contingent consideration liability | (7,063) | (1,642) |
| Goodwill impairment | 28,769 | — |
| Other | (410) | 87 |
| Change in operating assets and liabilities: | ||
| Accounts receivable, net | (2,709) | 6,304 |
Item 1. Financial Statements
FAQ
- What is Health Catalyst's contingent consideration fair value adjustments?
- Health Catalyst (HCAT) reported contingent consideration fair value adjustments of -$1.9M in Q3 2025.
- How has Health Catalyst's contingent consideration fair value adjustments changed year-over-year?
- Health Catalyst's contingent consideration fair value adjustments decreased by 15.4% year-over-year, from -$1.64M to -$1.9M.
- What does contingent consideration fair value adjustments mean?
- Contingent consideration fair value adjustments
Ask your AI about Health Catalyst's contingent consideration fair value adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude